In order to elucidate the possible mechanism involved, we performed GSEA to identify associated biological processes and signaling pathways using the mRNA signature based risk score for classification.
In order to ascertain whether the 10 miRNA expression signature based risk score is an independent predictor of GBM patient's survival, we carried out Cox multivariate analysis.
Finally, the scores were summarised to give the 'network based' risk score for every farm.
Only PIs associated with new infections were seen as relevant to validate the network based risk score.
If selective screening is indicated, our ethnicity based risk score performs well as a screening test for DM among these groups, particularly compared to the criteria based on age and/or body mass index derived from current guidelines.
Finally, to investigate our methodology's utility for constructing an empirically based risk score of patients, we added together the risks associated with each patient's heart rate, creatinine level and the set of nursing assessments, as recorded in the hospital's EHR, to obtain an overall 'risk score' and then tested the scores by ranking of discharge dispositions.
Currently, three cross-sectional design based risk scores [ 12- 14] and two cohort design based predictive models [ 15, 16] had been developed to predict MetS on different ethnicities.
About half of the 20 genes can individually achieve similar or better performance compared to clinical variable based risk scores, which further shows that the proposed approach can parsimoniously select high quality features.
Using a cohort of 109 patients with previously untreated CLL (GSE25571) [ 17], we investigated the association between the GE-based risk score and chromosomal abnormalities.
Interestingly, when compared using multivariate analysis, only the current GE-based risk score and NRIP1 and TCF7 expression, kept prognostic value.
Since GE-based risk score and NRIP1 and TCF7 expression displayed independent prognostic information, the prognostic information of the GE-based risk score was combined with those of TCF7 and NRIP1 gene expression into a single staging.
